title: The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.
abstract: OBJECTIVE
  To test the feasibility and utility of a bedside geriatric assessment (GA) to detect impairment in multiple geriatric domains in older adults initiating chemotherapy for acute myelogenous leukemia (AML).
  
  
  METHODS
  Prospective observational cohort study.
  
  
  METHODS
  Single academic institution.
  
  
  METHODS
  Individuals aged 60 and older with newly diagnosed AML and planned chemotherapy.
  
  
  METHODS
  Bedside GA was performed during inpatient exmination for AML. GA measures included the modified Mini-Mental State Examination; Center for Epidemiologic Studies Depression Scale; Distress Thermometer, Pepper Assessment Tool for Disability (includes self- reported activities of daily living (ADLs), instrumental ADLs, and mobility questions); Short Physical Performance Battery (includes timed 4-m walk, chair stands, standing balance); grip strength, and Hematopoietic Cell Transplantation Comorbidity Index.
  
  
  RESULTS
  Of 54 participants (mean age 70.8 ± 6.4) eligible for this analysis, 92.6% completed the entire GA battery (mean time 44.0 ± 14 minutes). The following impairments were detected: cognitive impairment, 31.5%; depression, 38.9%; distress, 53.7%; impairment in ADLs, 48.2%; impaired physical performance, 53.7%; and comorbidity, 46.3%. Most were impaired in one (92.6%) or more (63%) functional domains. For the 38 participants rated as having good performance status according to standard oncologic assessment (Eastern Cooperative Oncology Performance Scale score ≤1), impairments in individual GA measures ranged from 23.7% to 50%. Significant variability in cognitive, emotional, and physical status was detected even after stratification according to tumor biology (cytogenetic risk group classification).
  
  
  CONCLUSIONS
  Inpatient GA was feasible and added new information to standard oncology assessment, which may be important for stratifying therapeutic risk in older adults with AML.
authors.affiliation: Comprehensive Cancer Center, School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA. hklepin@wfubmc.edu
authors.forename: Heidi D
authors.initials: HD
authors.lastname: Klepin
authors.forename: Ann M
authors.initials: AM
authors.lastname: Geiger
authors.forename: Janet A
authors.initials: JA
authors.lastname: Tooze
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Kritchevsky
authors.forename: Jeff D
authors.initials: JD
authors.lastname: Williamson
authors.forename: Leslie R
authors.initials: LR
authors.lastname: Ellis
authors.forename: Denise
authors.initials: D
authors.lastname: Levitan
authors.forename: Timothy S
authors.initials: TS
authors.lastname: Pardee
authors.forename: Scott
authors.initials: S
authors.lastname: Isom
authors.forename: Bayard L
authors.initials: BL
authors.lastname: Powell
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D015897:Comorbidity; D004185:Disability Evaluation; D005240:Feasibility Studies; D005260:Female; D015577:Geriatric Assessment / Q000379:methods*; D006760:Hospitalization; D006801:Humans; D060828:Induction Chemotherapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D009657:North Carolina; D009730:Nursing Assessment; D011446:Prospective Studies
references.citation: Crit Rev Oncol Hematol. 2011 Feb;77(2):148-61
references.pmid: 20353897
references.citation: Cancer. 2005 Nov 1;104(9):1998-2005
references.pmid: 16206252
references.citation: Blood. 2006 May 1;107(9):3481-5
references.pmid: 16455952
references.citation: Blood. 2001 Sep 1;98(5):1312-20
references.pmid: 11520776
references.citation: J Clin Oncol. 2002 Jan 15;20(2):494-502
references.pmid: 11786579
references.citation: J Cancer Res Clin Oncol. 2006 Oct;132(10):665-71
references.pmid: 16821071
references.citation: Cancer. 2006 Mar 1;106(5):1090-8
references.pmid: 16435386
references.citation: Cancer. 2009 Oct 1;115(19):4547-53
references.pmid: 19562776
references.citation: Br J Haematol. 2007 Feb;136(4):624-7
references.pmid: 17223919
references.citation: Psychol Med. 1997 Jan;27(1):231-5
references.pmid: 9122304
references.citation: Ann Oncol. 2005 Nov;16(11):1795-800
references.pmid: 16093275
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4346-51
references.pmid: 19652074
references.citation: J Natl Compr Canc Netw. 2005 Jul;3(4):572-90
references.pmid: 16038647
references.citation: Blood. 2002 Aug 15;100(4):1224-32
references.pmid: 12149202
references.citation: Cancer. 1998 May 15;82(10):1904-8
references.pmid: 9587123
references.citation: Cancer. 2007 Apr 1;109(7):1376-83
references.pmid: 17326052
references.citation: Aging Clin Exp Res. 2006 Oct;18(5):359-66
references.pmid: 17167299
references.citation: Cancer. 2007 Feb 15;109(4):802-10
references.pmid: 17219443
references.citation: N Engl J Med. 2009 Sep 24;361(13):1235-48
references.pmid: 19776405
references.citation: Crit Rev Oncol Hematol. 2011 Feb;77(2):142-7
references.pmid: 20185330
references.citation: J Clin Oncol. 2010 Jan 10;28(2):348-56
references.pmid: 19996030
references.citation: Drugs Aging. 2005;22(11):943-55
references.pmid: 16323971
references.citation: Geriatr Gerontol Int. 2008 Mar;8(1):48-54
references.pmid: 18713189
references.citation: Blood. 2006 Nov 15;108(10):3262-70
references.pmid: 16857985
references.citation: J Geriatr Oncol. 2011 Jan;2(1):11-17
references.pmid: 23843929
references.citation: J Natl Compr Canc Netw. 2010 Apr;8(4):487-94
references.pmid: 20410338
references.citation: J Clin Oncol. 2007 May 10;25(14):1824-31
references.pmid: 17488980
references.citation: J Am Geriatr Soc. 2003 May;51(5):636-41
references.pmid: 12752838
references.citation: J Gerontol. 1994 Mar;49(2):M85-94
references.pmid: 8126356
references.citation: Blood. 2005 Oct 15;106(8):2912-9
references.pmid: 15994282
references.citation: Blood. 2010 Nov 25;116(22):4422-9
references.pmid: 20668231
references.citation: J Am Geriatr Soc. 1983 Dec;31(12):721-7
references.pmid: 6418786
references.citation: Arthritis Rheum. 2004 May;50(5):1501-10
references.pmid: 15146420
references.citation: JAMA. 1997 Jan 1;277(1):25-31
references.pmid: 8980206
references.citation: Blood. 2006 Nov 15;108(10):3280-8
references.pmid: 16840728
references.citation: J Am Geriatr Soc. 2010 Jan;58(1):76-82
references.pmid: 20122042
references.citation: Cancer Invest. 2004;22(5):678-87
references.pmid: 15581048
references.citation: J Clin Psychiatry. 1987 Aug;48(8):314-8
references.pmid: 3611032
references.citation: Blood. 2005 Oct 15;106(8):2646-54
references.pmid: 15994288
references.citation: Crit Rev Oncol Hematol. 2010 Dec;76(3):208-17
references.pmid: 20005123
references.citation: Crit Rev Oncol Hematol. 2010 May;74(2):97-105
references.pmid: 19520589
references.citation: Blood. 2001 Aug 1;98(3):548-53
references.pmid: 11468148
references.citation: Arch Intern Med. 2002 Jul 22;162(14):1597-603
references.pmid: 12123403
references.citation: J Clin Oncol. 1989 Sep;7(9):1268-74
references.pmid: 2475589
references.citation: Blood. 2006 Jul 1;108(1):63-73
references.pmid: 16522815